Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analyses

Miller, R. G., Zhang, R., Bracci, P. M., Azhir, A., Barohn, R., Bedlack, R., Benatar, M., Berry, J. D., Cudkowicz, M., Kasarskis, E. J., Mitsumoto, H., Manousakis, G., Walk, D., Oskarsson, B., Shefner, J., & McGrath, M. S. (2022). Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses. Muscle & Nerve, 66(1), 39–49. Portico. https://doi.org/10.1002/mus.27511
Authors:
Robert G. Miller
Rongzhen Zhang
Paige M. Bracci
Ari Azhir
Richard Barohn
Richard Bedlack
Michael Benatar
James D. Berry
Merit Cudkowicz
Edward J. Kasarskis
Hiroshi Mitsumoto
Georgios Manousakis
David Walk
Bjorn Oskarsson
Jeremy Shefner
Michael S. McGrath
Affiliated Authors:
Hiroshi Mitsumoto
Columbia Affiliation:
Subjects:
Amyotrophic Lateral Sclerosis (MeSH)
Author Keywords:
c-reactive protein (crp)
np001
amyotrophic lateral sclerosis (als)
inflammation
respiratory function
elink
Publication Type:
Article
Unique ID:
10.1002/mus.27511
PMID:
35098554
DOI:
10.1002/mus.27511
Journal:
Muscle and Nerve
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View PubMed Record

Record Created: